blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1287130

EP1287130 - MAMMALIAN CYTOKINE RECEPTOR SUBUNIT PROTEINS, RELATED REAGENTS AND METHODS [Right-click to bookmark this link]
StatusPatent maintained as amended
Status updated on  23.06.2017
Database last updated on 24.08.2024
Most recent event   Tooltip24.06.2022Lapse of the patent in a contracting state
New state(s): TR
published on 27.07.2022  [2022/30]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
[2017/30]
Former [2012/33]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway NJ 07065-0907 / US
Former [2008/21]For all designated states
Schering Corporation
2000 Galloping Hill Road
Kenilworth, NJ 07033-0530 / US
Former [2003/10]For all designated states
SCHERING CORPORATION
2000 Galloping Hill Road
Kenilworth, New Jersey 07033-0530 / US
Inventor(s)01 / CHIRICA, Madaline
6 Colonial Village Drive, Apt. 10
Arlington, MA 02474 / US
02 / KASTELEIN, Robert, A.
463 Summit Drive
Redwood City, CA 94062 / US
03 / MOORE, Kevin, W.
251 Carolina Lane
Palo Alto, CA 94306 / US
04 / PARHAM, Christi, L.
2385 30th Avenue
San Francisco, CA 94116 / US
 [2003/10]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2017/30]
Former [2012/24]HOFFMANN EITLE
Patent- und Rechtsanwälte
Arabellastraße 4
81925 München / DE
Former [2009/43]Taormino, Joseph Paul
Hoffmann - Eitle Patent- und Rechtsanwälte Arabellastraße 4
D-81925 München / DE
Former [2009/41]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Former [2008/32]Naylor, Kathryn May, et al
Mathys & Squire LLP 120 Holborn London
EC1N 2SQ / GB
Former [2006/23]Naylor, Kathryn May, et al
Mathys & Squire 120 Holborn
London EC1N 2SQ / GB
Former [2003/10]Ritter, Stephen David, et al
Mathys & Squire 100 Gray's Inn Road
London WC1X 8AL / GB
Application number, filing date01935242.610.05.2001
[2003/10]
WO2001US15057
Priority number, dateUS20000203426P10.05.2000         Original published format: US 203426 P
[2003/10]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0185790
Date:15.11.2001
Language:EN
[2001/46]
Type: A2 Application without search report 
No.:EP1287130
Date:05.03.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 15.11.2001 takes the place of the publication of the European patent application.
[2003/10]
Type: B1 Patent specification 
No.:EP1287130
Date:21.05.2008
Language:EN
[2008/21]
Type: B2 New European patent specification 
No.:EP1287130
Date:26.07.2017
Language:EN
[2017/30]
Search report(s)International search report - published on:EP18.07.2002
ClassificationIPC:C12N15/12, C07K14/715
[2012/11]
CPC:
C07K14/715 (EP,US); C07K14/705 (KR); A61P1/04 (EP);
A61P17/06 (EP); A61P19/00 (EP); A61P19/02 (EP);
A61P25/00 (EP); A61P25/28 (EP); A61P29/00 (EP);
A61P3/10 (EP); A61P31/00 (EP); A61P31/04 (EP);
A61P31/10 (EP); A61P31/12 (EP); A61P35/00 (EP);
A61P37/00 (EP); A61P37/06 (EP); A61P37/08 (EP);
A61P43/00 (EP); A61K38/00 (EP,US); C07K2319/00 (EP,US);
Y10S435/975 (EP,US) (-)
Former IPC [2003/10]C12N15/12
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2017/30]
Former [2003/10]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
Extension statesRO14.11.2002
SI14.11.2002
TitleGerman:ZYTOKINREZEPTORUNTEREINHEIT-PROTEINE AUS SÄUGETIEREN, DAMIT ZUSAMMENHÄNGENDE REAGENZIEN UND METHODEN[2003/10]
English:MAMMALIAN CYTOKINE RECEPTOR SUBUNIT PROTEINS, RELATED REAGENTS AND METHODS[2003/10]
French:PROTEINES DE RECEPTEUR DE MAMMIFERE, REACTIFS LIES ET TECHNIQUES[2003/10]
Entry into regional phase14.11.2002National basic fee paid 
14.11.2002Designation fee(s) paid 
14.11.2002Examination fee paid 
Examination procedure13.11.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
14.11.2002Amendment by applicant (claims and/or description)
14.11.2002Examination requested  [2003/10]
21.03.2005Despatch of a communication from the examining division (Time limit: M06)
27.09.2005Reply to a communication from the examining division
22.03.2006Despatch of a communication from the examining division (Time limit: M08)
01.12.2006Reply to a communication from the examining division
10.08.2007Communication of intention to grant the patent
20.12.2007Fee for grant paid
20.12.2007Fee for publishing/printing paid
Divisional application(s)EP07122991.8  / EP1918377
EP10177160.8  / EP2275548
Opposition(s)Opponent(s)01  20.02.2009  02.03.2009  ADMISSIBLE
Chugai Pharmaceutical Co., Ltd.
200 Kajiwara, Kamakura Kanagawa
247-8530 / JP
Opponent's representative
Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
 [2015/22]
Former [2009/14]
Opponent(s)01  20.02.2009   
Chugai Pharmaceutical Co., Ltd.
200 Kajiwara, Kamakura Kanagawa
247-8530 / JP
Opponent's representative
Vogelsang-Wenke, Heike
Grünecker Kinkeldey Stockmair & Schwanhäusser Anwaltssozietät Leopoldstrasse 4
80802 München / DE
27.03.2009Invitation to proprietor to file observations on the notice of opposition
06.10.2009Reply of patent proprietor to notice(s) of opposition
02.03.2011Date of oral proceedings
22.08.2011Despatch of minutes of oral proceedings
15.03.2012Despatch of interlocutory decision in opposition
30.01.2017Legal effect of interlocutory decision in opposition
16.03.2017Despatch of communication that the patent will be maintained as amended
08.06.2017Fee for printing new specification paid
Appeal following opposition14.05.2012Appeal received No.  T1223/12
13.07.2012Statement of grounds filed
30.01.2017Result of appeal procedure: appeal of the proprietor withdrawn
Fees paidRenewal fee
07.05.2003Renewal fee patent year 03
05.05.2004Renewal fee patent year 04
13.05.2005Renewal fee patent year 05
27.03.2006Renewal fee patent year 06
07.05.2007Renewal fee patent year 07
18.03.2008Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY10.05.2014
AT10.05.2016
FI10.05.2016
IE10.05.2016
IT10.05.2016
LU10.05.2016
TR10.05.2016
ES11.05.2016
SE11.05.2016
BE31.05.2016
CH31.05.2016
DK31.05.2016
LI31.05.2016
MC31.05.2016
NL01.06.2016
PT10.11.2016
[2022/30]
Former [2020/34]CY10.05.2014
AT10.05.2016
FI10.05.2016
IE10.05.2016
IT10.05.2016
LU10.05.2016
ES11.05.2016
SE11.05.2016
BE31.05.2016
CH31.05.2016
DK31.05.2016
LI31.05.2016
MC31.05.2016
NL01.06.2016
PT10.11.2016
Former [2018/32]CY10.05.2014
AT10.05.2016
FI10.05.2016
IE10.05.2016
IT10.05.2016
LU10.05.2016
SE11.05.2016
BE31.05.2016
CH31.05.2016
DK31.05.2016
LI31.05.2016
MC31.05.2016
NL01.06.2016
PT10.11.2016
Former [2018/11]CY10.05.2014
AT10.05.2016
FI10.05.2016
IE10.05.2016
IT10.05.2016
LU10.05.2016
SE11.05.2016
BE31.05.2016
CH31.05.2016
DK31.05.2016
LI31.05.2016
NL01.06.2016
PT10.11.2016
Former [2017/38]CY10.05.2014
AT10.05.2016
FI10.05.2016
IE10.05.2016
IT10.05.2016
LU10.05.2016
SE11.05.2016
BE31.05.2016
CH31.05.2016
DK31.05.2016
LI31.05.2016
NL01.06.2016
PT10.11.2016
GR07.12.2016
Former [2017/13]CY10.05.2014
AT10.05.2016
FI10.05.2016
IT10.05.2016
LU10.05.2016
SE11.05.2016
BE31.05.2016
CH31.05.2016
LI31.05.2016
NL01.06.2016
PT10.11.2016
GR07.12.2016
Former [2017/11]CY10.05.2014
AT10.05.2016
FI10.05.2016
IT10.05.2016
LU10.05.2016
SE11.05.2016
BE31.05.2016
CH31.05.2016
LI31.05.2016
PT10.11.2016
GR07.12.2016
Former [2017/10]CY10.05.2014
FI10.05.2016
LU10.05.2016
SE11.05.2016
BE31.05.2016
CH31.05.2016
LI31.05.2016
Former [2017/07]CY10.05.2014
LU10.05.2016
BE31.05.2016
CH31.05.2016
LI31.05.2016
Former [2017/04]CY10.05.2014
LU10.05.2016
BE31.05.2016
Former [2016/37]CY10.05.2014
BE31.05.2016
Former [2015/11]CY10.05.2014
Cited inInternational search[PX]WO0073451  (SCHERING CORP [US]) [PX] 1-21 * page 54, line 1 - page 63, line 3 * * page 64, line 1 - page 66, line 9 * * claims 1-20 *;
 [PX]WO0118051  (SCHERING CORP [US]) [PX] 1-21* page 30: VIII Uses.;; claims 1-47 *;
 [X]  - EMBL, XP002192058 [X] 1-21
 [X]  - EMBL, XP002192059 [X] 1-21
 [X]  - D. H. PRESKY ET AL., "A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits", PROC. NATL. ACAD. SCI. U.S.A, (1996), vol. 93, pages 14002 - 14007, XP002192057 [X] 1-21 * abstract * * page 14002, column 2, line 3 - column 2, line 6 * * page 14002, column 2, line 15 - column 2, line 22 * * page 1402, column 2, line 29 - column 2, line 34 * * page 14003, column 1, paragraphs 3,4 * * page 14003, column 2, paragraph 4 * * figure 1 * * page 14006, column 1, line 9 - line 27 * * page 14006, column 1, line 48 - line 57 * * page 14007, column 1, paragraph 2 *

DOI:   http://dx.doi.org/10.1073/pnas.93.24.14002
 [PX]  - EMBL, XP002192060 [PX] 1-21
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.